These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3085480)

  • 1. Plasmapheresis and antiplatelet agents in the treatment of the hemolytic uremic syndrome secondary to mitomycin.
    Chow S; Roscoe J; Cattran DC
    Am J Kidney Dis; 1986 May; 7(5):407-12. PubMed ID: 3085480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasmapheresis and antiplatelet agents in the treatment of the hemolytic uremic syndrome secondary to mitomycin.
    Murgo AJ
    Am J Kidney Dis; 1987 Mar; 9(3):241. PubMed ID: 3826074
    [No Abstract]   [Full Text] [Related]  

  • 3. Hemolytic-uremic syndrome and acute renal failure in metastatic adenocarcinoma treated with mitomycin: case report and literature review.
    D'Elia JA; Aslani M; Schermer S; Cloud L; Bothe A; Dzik W
    Ren Fail; 1987; 10(2):107-13. PubMed ID: 3120247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carcinoma-associated hemolytic-uremic syndrome: a complication of mitomycin C chemotherapy.
    Cantrell JE; Phillips TM; Schein PS
    J Clin Oncol; 1985 May; 3(5):723-34. PubMed ID: 3923162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hemolytic-uremic syndrome caused by mitomycin C].
    de Insausti CL; Gutiérrez LE
    Sangre (Barc); 1988 Aug; 33(4):319-20. PubMed ID: 3142062
    [No Abstract]   [Full Text] [Related]  

  • 6. Successful treatment of mitomycin C-associated hemolytic uremic syndrome by plasmapheresis.
    Garibotto G; Acquarone N; Saffioti S; Deferrari G; Villaggio B; Ferrario F
    Nephron; 1989; 51(3):409-12. PubMed ID: 2493141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of mitomycin-C-associated hemolytic uremic syndrome with plasmapheresis.
    Poch E; Almirall J; Nicolas JM; Torras A; Revert L
    Nephron; 1990; 55(1):89-90. PubMed ID: 2112726
    [No Abstract]   [Full Text] [Related]  

  • 8. [Chemotherapy-induced hemolytic uremic syndrome. A complication to mitomycin treatment of breast carcinoma].
    Schjølseth SA; Hagen T; Ottestad L; Jakobsen E
    Tidsskr Nor Laegeforen; 1995 Nov; 115(27):3371-3. PubMed ID: 7491579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitomycin-induced hemolytic-uremic syndrome. Successful treatment with corticosteroids and intense plasma exchange.
    Lyman NW; Michaelson R; Viscuso RL; Winn R; Mulgaonakar S; Jacobs MG
    Arch Intern Med; 1983 Aug; 143(8):1617-8. PubMed ID: 6870446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carcinoma-associated hemolytic-uremic syndrome in a patient receiving 5-fluorouracil-adriamycin-mitomycin C combination chemotherapy.
    Mergenthaler HG; Binsack T; Wilmanns W
    Oncology; 1988; 45(1):11-4. PubMed ID: 3124028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A syndrome of microangiopathic hemolytic anemia, renal impairment, and pulmonary edema in chemotherapy-treated patients with adenocarcinoma.
    Sheldon R; Slaughter D
    Cancer; 1986 Oct; 58(7):1428-36. PubMed ID: 3091244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemolytic-uremic syndrome after cancer chemotherapy without mitomycin C.
    Desablens B; Fievet P; Pruna A; Claisse JF; Westeel PF; Tolani M; Fournier A
    Nephron; 1986; 42(4):343-4. PubMed ID: 3083278
    [No Abstract]   [Full Text] [Related]  

  • 13. First-line and salvage therapy of metastatic breast cancer with mitomycin/vinblastine.
    Sedlacek SM
    Oncology; 1993 Apr; 50 Suppl 1():16-21. PubMed ID: 8483557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of mitomycin-associated microangiopathic hemolytic anemia with vincristine.
    Grem JL; Merritt JA; Carbone PP
    Arch Intern Med; 1986 Mar; 146(3):566-8. PubMed ID: 3954531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitomycin C associated hemolytic uremic syndrome.
    Jain S; Seymour AE
    Pathology; 1987 Jan; 19(1):58-61. PubMed ID: 3108839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Uremic hemolytic syndrome induced by mitomycin C. Presentation of a series of 5 cases and review of the literature].
    Nicolás JM; Villalta J; González-Clemente JM; Antúnez E; Almirall J; Bosch J; Torras A; Urbano-Márquez A
    Rev Clin Esp; 1990 Mar; 186(4):166-70. PubMed ID: 2114657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A case report of hemolytic uremic syndrome (HUS) induced by antineoplastic agents].
    Anai H; Okada Y; Okubo K; Korenaga D; Maehara Y; Sugimachi K; Ohi Y
    Nihon Gan Chiryo Gakkai Shi; 1990 Jul; 25(7):1487-91. PubMed ID: 2120375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary hypertension, hemolytic anemia, and renal failure. A mitomycin-associated syndrome.
    McCarthy JT; Staats BA
    Chest; 1986 Apr; 89(4):608-11. PubMed ID: 3082608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombotic thrombocytopenic purpura: failure of plasma infusion and antiplatelet agents.
    Stern R; Cornell CJ; Beck R; Smith RE
    Ann Intern Med; 1979 Jun; 90(6):989. PubMed ID: 571692
    [No Abstract]   [Full Text] [Related]  

  • 20. Cancer-associated hemolytic uremic syndrome.
    Hrozencik SP; Connaughton MJ
    Oncol Nurs Forum; 1988; 15(6):755-9. PubMed ID: 3205834
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.